Atlas Trials

Opioid Induced Constipation (OIC)

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Opioid Induced Constipation (OIC)

RecordFirmDate
A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation (NCT01395524)AstraZeneca2011-07-01
A Study to Assess the Safety, Tolerability and Clinical Activity of TD-1211 in Patients With Opioid-Induced Constipation (NCT01333540)Glycyx Therapeutics2011-05-01
Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation (NCT01336205)AstraZeneca2011-04-01
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation (NCT01323790)AstraZeneca2011-03-01
A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC) (NCT00600119)AstraZeneca2007-12-01

Track Opioid Induced Constipation (OIC) automatically

Every clearance here is in the API, with alerts when new ones post.